Total Payments
$1,991
2024 Payments
$400.57
Companies
16
Transactions
108
Medicare Patients
4,834
Medicare Billing
$229,605
Payment Breakdown by Category
Food & Beverage$1,979 (99.4%)
Education$11.51 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,979 | 107 | 99.4% |
| Education | $11.51 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $521.18 | 33 | $0 (2024) |
| ABBVIE INC. | $378.19 | 20 | $0 (2023) |
| Lilly USA, LLC | $217.16 | 7 | $0 (2023) |
| Horizon Therapeutics plc | $185.81 | 4 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $169.81 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $167.01 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $79.28 | 4 | $0 (2024) |
| PFIZER INC. | $76.69 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47.08 | 3 | $0 (2021) |
| Genentech USA, Inc. | $38.67 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $400.57 | 26 | Amgen Inc. ($215.29) |
| 2023 | $197.39 | 8 | Lilly USA, LLC ($79.43) |
| 2022 | $375.30 | 14 | Horizon Therapeutics plc ($143.25) |
| 2021 | $794.11 | 48 | AbbVie Inc. ($295.91) |
| 2020 | $223.36 | 12 | Amgen Inc. ($106.21) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $121.58 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/28/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/25/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/14/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/14/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/03/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Dermatology | ||||||
| 01/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,703 | 2,770 | $319,704 | $83,666 |
| 2022 | 31 | 1,619 | 2,750 | $254,393 | $77,251 |
| 2021 | 27 | 1,372 | 2,118 | $181,521 | $63,443 |
| 2020 | 9 | 140 | 176 | $16,446 | $5,244 |
Total Patients
4,834
Total Services
7,814
Medicare Billing
$229,605
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 148 | 223 | $74,227 | $28,426 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 77 | 77 | $32,384 | $11,214 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 117 | $25,649 | $9,520 | 37.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 16 | 72 | $33,480 | $6,437 | 19.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 79 | $17,775 | $3,669 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 50 | $8,314 | $3,014 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,180 | $2,640 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 198 | 313 | $6,314 | $2,612 | 41.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 172 | 252 | $16,128 | $2,603 | 16.1% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 55 | 110 | $10,340 | $2,304 | 22.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 167 | 251 | $14,558 | $1,910 | 13.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 57 | $6,897 | $1,113 | 16.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 33 | 38 | $6,670 | $1,102 | 16.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 28 | 57 | $5,519 | $1,095 | 19.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 17 | $4,324 | $947.53 | 21.9% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 137 | 174 | $13,572 | $879.45 | 6.5% |
| 72202 | X-ray of joint between lower spine and hip bone, 3 or more views | Office | 2023 | 30 | 30 | $4,650 | $647.70 | 13.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 20 | 36 | $3,413 | $472.32 | 13.8% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 136 | 173 | $6,000 | $456.11 | 7.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 43 | $2,200 | $455.81 | 20.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 19 | $1,689 | $280.82 | 16.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 16 | 16 | $1,474 | $248.01 | 16.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 26 | 38 | $304.00 | $231.39 | 76.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 68 | 75 | $1,950 | $230.60 | 11.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $1,392 | $193.16 | 13.9% |
About Dr. Katherine Kaufman, MD
Dr. Katherine Kaufman, MD is a Pediatric Pulmonology healthcare provider based in Pollocksville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982963245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Kaufman, MD has received a total of $1,991 in payments from pharmaceutical and medical device companies, with $400.57 received in 2024. These payments were reported across 108 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,979).
As a Medicare-enrolled provider, Kaufman has provided services to 4,834 Medicare beneficiaries, totaling 7,814 services with total Medicare billing of $229,605. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Pulmonology
- Other Specialties Pediatric Rheumatology, Student in an Organized Health Care Education/Training Program
- Location Pollocksville, NC
- Active Since 05/08/2012
- Last Updated 11/14/2022
- Taxonomy Code 2080P0214X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982963245
Products in Payments
- Enbrel (Biological) $331.39
- KRYSTEXXA (Biological) $315.99
- RINVOQ (Biological) $270.55
- LUPKYNIS (Drug) $169.81
- BENLYSTA (Biological) $167.01
- TALTZ (Drug) $146.59
- XELJANZ (Drug) $76.69
- COSENTYX (Biological) $63.81
- HUMIRA (Biological) $51.54
- Actemra (Biological) $38.67
- EVENITY (Biological) $33.61
- Cimzia (Drug) $32.73
- OFEV (Drug) $32.20
- RINVOQ (Drug) $27.50
- QELBREE (Drug) $18.76
- COSENTYX (Drug) $15.47
- ULTOMIRIS (Biological) $15.09
- HUMIRA (Drug) $14.58
- Otezla (Drug) $14.49
- Vascepa (Drug) $13.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.